{"schema_version":"secwatch.filing_event.v1","accession":"0001725160-25-000164","form_type":"8-K","ticker":"ZNTL","cik":"0001725160","company_name":"Zentalis Pharmaceuticals, Inc.","filed_at":"2025-12-15T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.260001+00:00","generated_at":"2026-05-16T13:14:14.497955+00:00","sec_items":["5.01","8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Zentalis repurchases 7.5M shares from Matrix at $1.33 each; director resigns","bullets":["Repurchased 7,500,000 shares from Matrix Capital Master Fund at $1.33/share, a 5% discount to the Dec 12 close of $1.40.","Repurchase closed on December 15, 2025; funded by existing cash, with no material impact on projected cash runway into late 2027.","Director Karan Takhar (Matrix Capital) resigned immediately, reducing board size from 7 to 6; resignation not due to any disagreement.","Matrix's sale is part of its previously announced 2024 plan to wind down its family of funds."],"urls":{"canonical":"https://secwatch.observer/filing/0001725160-25-000164","json":"https://secwatch.observer/filing/0001725160-25-000164.json","markdown":"https://secwatch.observer/filing/0001725160-25-000164.md","text":"https://secwatch.observer/filing/0001725160-25-000164.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725160/000172516025000164/0001725160-25-000164-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725160/000172516025000164/zntl-20251215.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T13:14:14.497955+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}